Clinical Trials Browser

Phase 1 × Thymoma × Imatinib Mesylate × Clear all

NCT00314873 2014-06-03

Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma

Phase 1 Completed

Thymoma